When the drug Vioxx was pulled from the market by pharmaceutical company Merck due to its association with heart problems the demand for other pain medications?

When Vioxx was pulled from the market due to its association with increased cardiovascular risks, the demand for alternative pain medications, such as non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen, likely increased as patients and healthcare providers sought safer options. Additionally, there was a growing interest in non-pharmacological pain management approaches. The withdrawal also prompted further scrutiny and research into the safety profiles of other pain medications, influencing prescribing practices. Overall, the market dynamics shifted as consumers looked for effective yet safer alternatives.